Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
M Asrih, FR Jornayvaz - Molecular and cellular endocrinology, 2015 - Elsevier
Metabolic syndrome (MetS) is a disease composed of different risk factors such as obesity,
type 2 diabetes or dyslipidemia. The prevalence of this syndrome is increasing worldwide in …
type 2 diabetes or dyslipidemia. The prevalence of this syndrome is increasing worldwide in …
[HTML][HTML] What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
C Finelli, G Tarantino - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type of chronic
liver disease in Western countries. Insulin resistance is a key factor in the pathogenesis of …
liver disease in Western countries. Insulin resistance is a key factor in the pathogenesis of …
[图书][B] Handbook of Obesity--Volume 1: Epidemiology, Etiology, and Physiopathology
GA Bray - 2014 - books.google.com
In recent years, we've developed a much better grasp of the biological and other factors
associated with the development of obesity. Reflecting our evolving understanding of …
associated with the development of obesity. Reflecting our evolving understanding of …
[HTML][HTML] What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
G Tarantino, C Finelli - World journal of gastroenterology: WJG, 2013 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is currently not a component of the diagnostic
criteria for metabolic syndrome (MetS); however, the development of NAFLD has some …
criteria for metabolic syndrome (MetS); however, the development of NAFLD has some …
[HTML][HTML] Liver-spleen axis: intersection between immunity, infections and metabolism
G Tarantino, A Scalera, C Finelli - World journal of …, 2013 - ncbi.nlm.nih.gov
Spleen has been considered a neglected organ so far, even though is strictly linked to liver.
The spleen plays an important role in the modulation of the immune system and in the …
The spleen plays an important role in the modulation of the immune system and in the …
[HTML][HTML] The detection and role of heat shock protein 70 in various nondisease conditions and disease conditions: a literature review
B Qu, Y Jia, Y Liu, H Wang, G Ren, H Wang - Cell Stress and Chaperones, 2015 - Elsevier
As an intracellular polypeptide, heat shock protein 70 (HSP70) can be exposed on the
plasma membrane and/or released into the circulation. However, the role of HSP70 in …
plasma membrane and/or released into the circulation. However, the role of HSP70 in …
Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis
Background Simvastatin exerts pleiotropic effects on cardiovascular system. However, its
effect on non-alcoholic fatty liver disease, especially the liver fibrosis, remains obscure. We …
effect on non-alcoholic fatty liver disease, especially the liver fibrosis, remains obscure. We …
Antioxidant enzyme activity and serum HSP70 concentrations in relation to insulin resistance and lipid profile in lean and overweight young men
A Lubkowska, W Dudzińska, W Pluta - Antioxidants, 2023 - mdpi.com
Oxidants are generated by all cells during normal oxidative respiration, and as long as they
are under the control of appropriate mechanisms, they act as intracellular signaling …
are under the control of appropriate mechanisms, they act as intracellular signaling …
A high‐fat, high‐fructose diet induces antioxidant imbalance and increases the risk and progression of nonalcoholic fatty liver disease in mice
K Jarukamjorn, N Jearapong, C Pimson… - …, 2016 - Wiley Online Library
Excessive fat liver is an important manifestation of nonalcoholic fatty liver disease (NAFLD),
associated with obesity, insulin resistance, and oxidative stress. In the present study, the …
associated with obesity, insulin resistance, and oxidative stress. In the present study, the …
An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer
R Chatterjee, A Mitra - International immunopharmacology, 2015 - Elsevier
Chronic liver diseases (CLDs) such as hepatitis, alcoholic liver disease, nonalcoholic fatty
liver, and their downstream effect cancer affect more than a billion of people around the …
liver, and their downstream effect cancer affect more than a billion of people around the …